First-line rituximab good value for NHL in the UK

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1572, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK

By Ray Joshua A.   Carr Emma   Lewis Gavin   Marcus Robert  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 346-357

Blackwell Publishing

Access to resources Recommend Favorite

Venlafaxine worthwhile for first-line depression treatment in the UK

By  

Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Rituximab + CHOP: first-line therapy in B-cell lymphoma

By  

Inpharma, Vol. 1, Iss. 1323, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

NHL gets the CHOP with rituximab

By  

Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Rituximab: As First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma

By Croxtall Jamie D.  

Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. : 885-895

Adis International

Access to resources Recommend Favorite